A combined fracture and mortality risk index useful for treatment stratification in hip fragility fractures

Objectives In this study, we aimed to assess the stratification ability of the Fracture and Mortality Risk Evaluation (FAME) index for reoperation, new fragility fracture, and mortality during one-year follow-up. Patients and methods Between November 2018 and July 2019, a total of 94 consecutive hip fragility fracture patients from two centers (20 males, 74 females; mean age: 79.3±8.9 years; range, 57 to 100 years) were retrospectively analyzed. The patients were classified into high, intermediate, and low fracture and mortality risk groups according to the Fracture Risk Assessment Tool (FRAX) score and Sernbo score, respectively, as well as nine combined categories according to the FAME index. Hospital records were reviewed to identify re-fractures (reoperations, implant failure, new fragility fractures on any site) and mortality at one year following the FAME index classification. Results Overall re-fracture and mortality rates were 20.2% and 33%, respectively. High fracture risk category (FRAX-H) was significantly associated with higher re-fracture (odds ratio [OR]: 2.9, 95% confidence interval [CI]: 1-8.2, p=0.037) and mortality rates compared to others (OR: 3.7, 95% CI: 1.5-9.3, p=0.003). The patients classified within the FRAX-H category (n=35) had different mortality rates according to their Sernbo classification; i.e., patients classified as low mortality risk (Sernbo-L) (n=17) had lower mortality rates compared to others in this group (n=18) (35.3% and 66.7%, respectively), indicating a low statistical significance (OR: 0.3, 95% CI: 0.1-1.1, p=0.063). Similarly, within patients classified in Sernbo-L category (n=64), those classified as high fracture risk (FRAX-H) (n=17) had significantly higher re-fracture rates compared to others in this group (n=47) (35.3% and 8.5%, respectively), (OR: 5.9; 95% CI: 1.4-24.5), (p=0.017). Multivariate logistic regression analyses adjusting for covariates (age, sex, length of hospital stay and BMI) yielded similar results. Conclusion The FAME index appears to be a useful stratification tool for allocating patients in a randomized-controlled trial for augmentation of hip fragility fractures.

[1]  L. Lidgren,et al.  Augmenting a dynamic hip screw with a calcium sulfate/hydroxyapatite biomaterial. , 2021, Medical engineering & physics.

[2]  Brian P. Cunningham,et al.  Trend and Economic Implications of Implant Selection in the Treatment of Intertrochanteric Hip Fractures: A Review of the American Board of Orthopaedic Surgery Database From 2007 to 2017 , 2021, The Journal of the American Academy of Orthopaedic Surgeons.

[3]  F. Tubach,et al.  Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study , 2021, JBMR plus.

[4]  M. Gardner,et al.  Indications for cement augmentation in fixation of geriatric intertrochanteric femur fractures: a systematic review of evidence , 2021, Archives of Orthopaedic and Trauma Surgery.

[5]  R. Morochovič.  Reversed Z-effect and Z-effect phenomena in femoral neck fracture treated with a dynamic locking plate fixation: Case report , 2020, Joint diseases and related surgery.

[6]  F. Doğar,et al.  A multicenter intertrochanteric fracture study in the elderly: Hemiarthroplasty versus proximal femoral nailing , 2020, Joint Diseases and Related Surgery.

[7]  O. Sköldenberg,et al.  The Sernbo score as a predictor of 1-year mortality after hip fracture: a registry study on 55,716 patients , 2020, European Journal of Trauma and Emergency Surgery.

[8]  E. Sezgin,et al.  Combined fracture and mortality risk evaluation for stratifying treatment in hip fracture patients: A feasibility study , 2020, Joint diseases and related surgery.

[9]  L. Lidgren,et al.  Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats , 2020, Tissue engineering. Part A.

[10]  L. Lidgren,et al.  Biomodulation of an Implant for Enhanced Bone-Implant Anchorage. , 2019, Acta biomaterialia.

[11]  B. Gabbe,et al.  Total hip arthroplasty versus hemiarthroplasty for independently mobile older adults with intracapsular hip fractures , 2019, BMC Musculoskeletal Disorders.

[12]  L. Lidgren,et al.  Fracture strength of the proximal femur injected with a calcium sulfate/hydroxyapatite bone substitute , 2019, Clinical biomechanics.

[13]  L. Lidgren,et al.  A ceramic bone substitute containing gentamicin gives good outcome in trochanteric hip fractures treated with dynamic hip screw and in revision of total hip arthroplasty: a case series , 2018, BMC Musculoskeletal Disorders.

[14]  L. Lidgren,et al.  Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats , 2018, Tissue engineering. Part A.

[15]  J. Magaziner,et al.  A global call to action to improve the care of people with fragility fractures. , 2018, Injury.

[16]  S. Kim,et al.  Is calcium phosphate augmentation a viable option for osteoporotic hip fractures? , 2018, Osteoporosis International.

[17]  P. Trueman,et al.  Comparison of a twin interlocking derotation and compression screw cephalomedullary nail (InterTAN) with a single screw derotation cephalomedullary nail (proximal femoral nail antirotation): a systematic review and meta-analysis for intertrochanteric fractures , 2018, Journal of Orthopaedic Surgery and Research.

[18]  M. Javaid,et al.  Costs of fragility hip fractures globally: a systematic review and meta-regression analysis , 2017, Osteoporosis International.

[19]  P. Morberg,et al.  The Sernbo score predicts 1-year mortality after displaced femoral neck fractures treated with a hip arthroplasty , 2017, Acta orthopaedica.

[20]  C. Cooper,et al.  UK clinical guideline for the prevention and treatment of osteoporosis , 2017, Archives of Osteoporosis.

[21]  C. Kammerlander,et al.  The use of augmentation techniques in osteoporotic fracture fixation. , 2016, Injury.

[22]  Xiaobing Yin,et al.  Outcome of Hemiarthroplasty and Total Hip Replacement for Active Elderly Patients with Displaced Femoral Neck Fractures: A Meta-Analysis of 8 Randomized Clinical Trials , 2014, PloS one.

[23]  J. Eisman,et al.  Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[25]  Y. Gustafson,et al.  The hip fracture incidence curve is shifting to the right , 2009, Acta orthopaedica.

[26]  P. Mattsson,et al.  Resorbable cement for the augmentation of internally-fixed unstable trochanteric fractures. A prospective, randomised multicentre study. , 2005, The Journal of bone and joint surgery. British volume.

[27]  Christoph Fankhauser,et al.  Femoroplasty-augmentation of mechanical properties in the osteoporotic proximal femur: a biomechanical investigation of PMMA reinforcement in cadaver bones. , 2004, Clinical biomechanics.